{
    "id": 2754,
    "fullName": "LTK F568L",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "LTK F568L lies within the protein kinase domain of the Ltk protein (UniProt.org). F568L results in increased kinase activity and confers transforming ability in cell based assays (PMID: 22347506).",
            "references": [
                {
                    "id": 1347,
                    "pubMedId": 22347506,
                    "title": "ALK-activating homologous mutations in LTK induce cellular transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22347506"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4058,
        "geneSymbol": "LTK",
        "terms": [
            "LTK",
            "TYK1"
        ]
    },
    "variant": "F568L",
    "createDate": "12/17/2014",
    "updateDate": "10/07/2018",
    "referenceTranscriptCoordinates": {
        "id": 151556,
        "transcript": "NM_002344",
        "gDna": "chr15:g.41505526A>G",
        "cDna": "c.1702T>C",
        "protein": "p.F568L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1470,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the ALK inhibitor Xalkori (crizotinib) inhibited viability and proliferation of transformed cells expressing LTK F568L in culture (PMID: 22347506).",
            "molecularProfile": {
                "id": 2573,
                "profileName": "LTK F568L"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1347,
                    "pubMedId": 22347506,
                    "title": "ALK-activating homologous mutations in LTK induce cellular transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22347506"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2573,
            "profileName": "LTK F568L",
            "profileTreatmentApproaches": [
                {
                    "id": 6041,
                    "name": "Crizotinib",
                    "profileName": "LTK F568L"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 151556,
            "transcript": "NM_002344",
            "gDna": "chr15:g.41505526A>G",
            "cDna": "c.1702T>C",
            "protein": "p.F568L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}